Generate Biomedicines
GENB----
Generate Biomedicines (GENB)
Generate Biomedicines, Inc., engaged in the field of generative biology by using machine learning for drug discovery and development through the programming of...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- --
- Volume
- --
- Turnover
- --
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- --
- Turnover Ratio
- --
Generate Biomedicines Analyst Rating
View MoreForecast & Rating
May 14, 2026Price forecast
$25.4082.73%
Forecast & RatingStrong buy
6analysts
- Strong buy66.67%
- Buy33.33%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- Global Report · 14 hours ago
Tech Pivots to Cloud Mega-Deals as AI Momentum Spills Into Biopharma
- Global Report · 1 day ago, 04:13 AM
Deconstructing the Value Chain of the Long Tail: From Physical Scarcity to Niche Aggregation
- Global Report · Jul 19 at 04:13 AM
The Great Biotech Reckoning: When AI and Gene Editing Meet Wall Street's Patience in 2026
- Global Report · Jul 18 at 04:13 AM
M&A, AI Drug Discovery, and Late-Stage Clinical Readouts Define US Biotech Q2 Trajectory
- benzinga_article · Jul 1 at 07:02 AM
Nike, Shutterstock And Other Big Stocks Moving Lower In Wednesday’s Pre-Market Session
- benzinga_article · Jun 29 at 10:04 PM
Cathie Wood Loads Up On Amazon Stock After Record $26.4 Billion Prime Day, Bets Big On Palantir's AI Push — Keeps Dumping Alibaba
